Ablation of xanthelasma palpebrarum by ultrapulsed carbon dioxide laser
DOI:
https://doi.org/10.66344/jpad.28.4.2018.1175Keywords:
Xanthelasma, laser, CO2, ablation, ultrapulsedAbstract
Objective To investigate the efficacy and safety of ultrapulsed carbon dioxide (UCO2) laser ablation in  xanthelasma palpebrarum (XP) management. Methods Between January 2015 and December 2015, eleven Libyan female patients with 21 xanthelasma lesions were treated with one laser session using UCO2 laser. All patients were followed up for 6 months period. Results The 21 xanthelasma lesions were completely removed after one UCO2 laser session. During post-laser treatment follow-up period, 2 (9.5%) xanthelasma lesions showed transient hyperpigmentation for four months, which faded thereafter. None of the studied patients showed scarring and all patents were very satisfied with the end result of the ultrapulsed CO2 laser treatment. Conclusion UCO2 laser is an authentic therapeutic option and represents a convenient option to the conventional methods of xanthelasma management.ÂReferences
Raulin C, Schoenermark P, Werner S, Greve B. Xanthelasma palpebrarum treatment with ultrapulsed CO2 laser. Lasers Surg Med. 1999;24:122-7.
Reddy K, Kunneth T, Lakshminarayana P, Yallappa M, Chandrashekara R, Nanjundaswamy SK. Comparative study to evaluate the efficacy of radiofrequency ablation versus trichloroacetic acid in the treatment of xanthelasma palpebrarum. J Cutan Aesthet Surg. 2016;9:236-40.
Pathania V, and Chatterjee M. Ultrapulse carbon dioxide laser ablation of xanthelasma palpebrarum: A case series. J Cutan Aesthet Surg. 2015;8:46-9.
Corradino B, Di Lorenzo S, Triolo A, Moschella F. Laser treatment of giant xanthelasma palpebrarum. Lasers Med Sci. 2015;30:2205-7.
Abdelkadera M, Alashry SE. Argon laser versus erbium:YAG laser in the treatment of xanthelasma palpebrarum. Saudi J Ophthalmol. 2015;29:116-20.
Borelli C, Kaudewitz P. Xanthelasma palpebrarum: Treatment with the Erbium: YAG laser. Lasers Surg Med. 2001;29:260-4.
Fusade T. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd: YAG laser: A study of 11 cases. Br J Dermatol. 2008;158:84-7.
Karsai S, Czarnecka A, Raulin C. Treatment of xanthelasma palpebrarum using a pulsed dye laser: A prospective clinical trial in 38 cases. Dermatol Surg. 2010;36:610-7.
Park EJ, Youn SH, Cho EB, Lee GS, Hann SK, Kim KH et al. Xanthelasma palpebrarum treatment with a 1,450-nm-diode laser. Dermatol Surg. 2011;37:791-6.
Nguyen AH, Vaudreuil AM, Huerter CJ. Systematic review of laser therapy in xanthelasma palpebrarum. Int J Dermatol. 2017;56:47-55.
Nair PA, Patel CR, Ganjiwale JD, Diwan NG, Jivani NB. Xanthelasma palpebrarum with arcus cornea: A clinical and biochemical study. Indian J Dermatol. 2016;61:295-300.
Rohrich RJ, Janis JE, Pownell PH. Xanthelasma Palpebrarum: A Review and Current Management Principles. Plast Reconstr Surg. 2002;110:1310-3.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
